Transactions carried out under the share buy-back program

Report this content

Please see below information about transactions made under the share buy-back programme for Nordhealth AS (“Nordhealth”) (Ticker: NORDH NO).

Date on which the share buy-back programme was announced: 5 June 2023.

The duration of the buy-back programme: 5 June 2023 until no later than 31 December 2023 or the maximum share size or consideration has been reached.

Size of the buy-back programme: Up to 400,000 shares, for a maximum consideration of NOK 4,000,000.

From 5 June 2023 until 13 June 2023, Nordhealth has purchased a total of 20,878 own shares at an average price of NOK 23.2015 per share.

Aggregated overview of transactions per day:

Date Aggregate daily volume (# of shares) Weighted average price (NOK) Total transaction value (NOK)
05.06.2023 00:00:00 1,721 24.4023 41,996.36
06.06.2023 00:00:00 760 23.9720 18,218.72
07.06.2023 00:00:00 605 23.8354 14,420.42
08.06.2023 00:00:00 0 n.a. n.a.
09.06.2023 00:00:00 0 n.a. n.a.
12.06.2023 00:00:00 17,791 23.0309 409,742.74
13.06.2023 00:00:00 1 23.6000 23.60
Previously disclosed buy-backs under the programme (aggregate) 0 n.a. 0.00
Total purchased under the programme 20,878 23.2015 484,401.84

This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.

For further information, please contact:

Mari Orttenvuori, CFO

+358 46 8765 233

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 380 employees working either remotely or from offices (collaboration hubs). Visit the company’s website at